medscape.com
Crohn's Risk Stratification: Optimizing Patient Care - Medscape
Risk stratification helps identify people with Crohn's who are more likely to develop strictures, fistulas, or need surgery so clinicians can monitor and treat them more aggressively early on. Objective tests like fecal calprotectin, CRP, endoscopy, and cross-sectional imaging are central to that approach.
Adults with Crohn's disease, clinicians who care for IBD patients, patients on or considering biologic therapy, and researchers interested in prognostic markers.
What To Know
This Medscape commentary reviews risk stratification in Crohn's disease and how clinical features, biomarkers, endoscopy, and imaging are used to identify low- versus moderate/high-risk patients and guide treatment decisions.
The author outlines key clinical and demographic high-risk features (younger age at onset, ileal/ileocolonic location, perianal disease, prior surgery, smoking, certain genes) and describes commonly used activity scores (CDAI, HBI) and objective monitoring tools (CRP, fecal calprotectin, endoscopy with SES-CD, MRE/CTE).
He emphasizes identifying patients at diagnosis or during monitoring to tailor therapy aimed at preventing stricturing, penetrating disease, and other complications.
The piece also summarizes how imaging detects transmural inflammation and complications (strictures, fistulae, abscess) that often prompt earlier medical or surgical intervention, and notes that treatment intensity should match risk category. This is a clinical-review style commentary rather than new trial data; disclosures are listed for the author.
This is an expert commentary summarizing current clinical practice and tools for risk stratification; it does not present new randomized trial results. Recommendations reflect commonly used scores and imaging modalities; individual care decisions should be made with treating clinicians.
